AB

Alfred Bowie

Chief Financial Officer


Position and Company


Alfred “Freddie” Bowie serves as the Chief Financial Officer (CFO) at Eikon Therapeutics, an innovative company situated at the intersection of biotechnology and advanced research tools.

Professional Responsibilities


At Eikon Therapeutics, Alfred Bowie oversees several critical functions:
  • Finance

  • Corporate Strategy

  • Investor Relations

  • Corporate Communications

  • Procurement

  • Clinical Supply

  • Real Estate


Professional Background


Previous Experience


  • Veracyte: As a senior executive, Alfred led strategic and operational aspects, including corporate and business development, strategic planning, and sales operations. He was instrumental in spearheading collaborations with high-profile companies like Bayer, AstraZeneca, and Johnson & Johnson. During his tenure, he orchestrated multiple acquisitions.


  • Foundation Medicine: As the Senior Director of Corporate Development and Strategy, Alfred was responsible for strategic planning, corporate development, and competitive intelligence. Foundation Medicine is a fully owned subsidiary of Roche.


  • Tecan Group and Danaher Corporation: Alfred has also served in various corporate and business development roles in these leading biotechnology and life sciences companies.


Educational Background


  • Ph.D. in Synthetic Organic Chemistry from the University of California, Berkeley

  • Bachelor’s Degree in Chemistry from Davidson College, North Carolina


Recent Activities and Posts


Alfred is highly active on LinkedIn, where he shares corporate updates and employee recruitment posts. Highlights include:
  • May 28, 2024: Praised the advancements in the company's drug discovery and development platform.

  • February 13, 2024: Shared a post about Eikon Therapeutics revolutions in therapeutic research and development.

  • January 8, 2024: Discussed the exciting pipeline progress of the company at clinical and pre-clinical stages.

  • December 1, 2023: Announced a leadership role opening, emphasizing the need for experts in fundraising and deal-making.

  • November 14, 2023: Shared a post about contributing to the community through Eikon's initiatives.


Company Locations


  • Primary Location: 3929 Point Eden Way, Hayward, CA 94545

  • East Coast Base: Alexandria Center for Life Science, 450 East 29th St, New York, NY 10016

  • Additional Facility: 24590 Clawiter Road, Hayward, CA 94545

  • Jersey City Office: 3 2nd St, 4th Floor, Jersey City, NJ 07302


Contact Information


  • Phone: (341) 777-0566


Strategic Insights


Alfred Bowie’s strong background in corporate strategy and investor relations, combined with his robust educational credentials and extensive industry experience at high-profile biotech companies, makes him a critical figure in Eikon Therapeutics' leadership team. His strategic collaborations and operational efficiencies could be pivotal points for discussing potential partnerships or investment opportunities.




Key emphasis should be placed on his overarching control over the financial and strategic domains of Eikon Therapeutics and his proactive engagement on LinkedIn, which reflects his commitment to the company and the industry at large.